NASDAQ:CRSP

Crispr Therapeutics Stock Predictions

etoro logo Buy CRSP
*Your capital is at risk
$52.08
+0.0600 (+0.115%)
At Close: Jun 03, 2026
Currently predicting for Thu, 4 Jun 2026

CRSP Prediction Chart

CRSP Predictions History

Latest community submissions for CRSP.
Predictor Target Session Target Price Result Direction Accuracy Score
Aug 5, 2025 Bullish $55.59 X 0
Aug 4, 2025 $57.58 +2.65% $59.59 V 96.62% 1
Aug 4, 2025 $57.02 +1.66% $59.59 V 95.69% 1
Aug 4, 2025 Bullish $59.59 V 1
Jul 23, 2025 Bullish $68.14 V 1
Jul 18, 2025 $56.21 +2.04% $65.13 V 86.31% 1
Jul 18, 2025 $55.79 +1.28% $65.13 V 85.66% 1
Jun 25, 2025 $46.20 -1.24% $47.66 X 96.94% 0
Jun 25, 2025 Bullish $47.66 V 1
Jun 10, 2025 Bearish $42.94 X 0
Click to get the best stock tips daily for free!
Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for CRSP with a full price path, not just a one-day call.
  • Price path
  • Approved predictor
  • 3-month horizon
ABOUT CRISPR THERAPEUTICS AG
CRISPR Therapeutics
CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious diseases using its proprietary Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform. Its CRISPR/Cas9 is a gene editing technology that allows for precise directed changes to genomic DNA. The company has a portfolio of therapeutic programs across a range of disease areas, including hemoglo...
GOLDEN STAR
Ticker Change Signal Date
LITE
$905.00
3.65% Jun 01
RUN
$12.83
15.74% May 06
GLBE
$31.61
0.569% May 05
SAP
$172.39
4.80% May 05
ADBE
$243.57
5.20% Apr 29

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE